Identifying Genes Linked to Neuroblastoma Outcomes
Author Information
Author(s): Carén Helena, Djos Anna, Nethander Maria, Sjöberg Rose-Marie, Kogner Per, Enström Camilla, Nilsson Staffan, Martinsson Tommy
Primary Institution: University of Gothenburg
Hypothesis
Can epigenetically regulated genes predict patient outcomes in neuroblastoma?
Conclusion
Low methylation frequency of certain genes is significantly associated with favorable outcomes in neuroblastoma.
Supporting Evidence
- Eight genes were identified as methylated in neuroblastoma, some of which distinguish between biological subsets.
- Differential methylation was observed for SCNN1A, PRKCDBP, and KRT19.
- The mRNA expression of KRT19 and PRKCDBP was significantly lower in patients who died from the disease.
Takeaway
Researchers found that some genes can help predict how well children with neuroblastoma will do, based on their DNA changes.
Methodology
The study involved treating neuroblastoma cell lines with demethylating agents and analyzing gene expression and DNA methylation.
Limitations
The study had a relatively small sample size of 59 tumors, and findings need to be verified in larger cohorts.
Participant Demographics
Pediatric patients with neuroblastoma.
Statistical Information
P-Value
p = 0.01 for KRT19 and p = 0.04 for PRKCDBP
Confidence Interval
95% CI 1.7-19.1 for MYCN amplification
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website